Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.
Identifieur interne : 000469 ( Main/Exploration ); précédent : 000468; suivant : 000470Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.
Auteurs : Maristella De Cicco [Allemagne] ; Lech-G Milroy [Pays-Bas] ; Sonja A. Dames [Allemagne]Source :
- Protein science : a publication of the Protein Society [ 1469-896X ] ; 2018.
Descripteurs français
- KwdFr :
- Conformation des protéines (MeSH), Dichroïsme circulaire (MeSH), Domaines protéiques (MeSH), Humains (MeSH), Liposomes (métabolisme), Membrane cellulaire (métabolisme), Micelles (MeSH), Modèles moléculaires (MeSH), Mutation (MeSH), Phosphatidylinositol 3-kinases (composition chimique), Phosphatidylinositol 3-kinases (génétique), Phosphatidylinositol 3-kinases (métabolisme), Protéines de Saccharomyces cerevisiae (composition chimique), Protéines de Saccharomyces cerevisiae (génétique), Protéines de Saccharomyces cerevisiae (métabolisme), Protéines de fusion recombinantes (composition chimique), Protéines de fusion recombinantes (génétique), Protéines de liaison au tacrolimus (composition chimique), Protéines de liaison au tacrolimus (génétique), Protéines de liaison au tacrolimus (métabolisme), Résonance magnétique nucléaire biomoléculaire (MeSH), Saccharomyces cerevisiae (composition chimique), Saccharomyces cerevisiae (métabolisme), Simulation de dynamique moléculaire (MeSH).
- MESH :
- composition chimique : Phosphatidylinositol 3-kinases, Protéines de Saccharomyces cerevisiae, Protéines de fusion recombinantes, Protéines de liaison au tacrolimus, Saccharomyces cerevisiae.
- génétique : Phosphatidylinositol 3-kinases, Protéines de Saccharomyces cerevisiae, Protéines de fusion recombinantes, Protéines de liaison au tacrolimus.
- métabolisme : Liposomes, Membrane cellulaire, Phosphatidylinositol 3-kinases, Protéines de Saccharomyces cerevisiae, Protéines de liaison au tacrolimus, Saccharomyces cerevisiae.
- Conformation des protéines, Dichroïsme circulaire, Domaines protéiques, Humains, Micelles, Modèles moléculaires, Mutation, Résonance magnétique nucléaire biomoléculaire, Simulation de dynamique moléculaire.
English descriptors
- KwdEn :
- Cell Membrane (metabolism), Circular Dichroism (MeSH), Humans (MeSH), Liposomes (metabolism), Micelles (MeSH), Models, Molecular (MeSH), Molecular Dynamics Simulation (MeSH), Mutation (MeSH), Nuclear Magnetic Resonance, Biomolecular (MeSH), Phosphatidylinositol 3-Kinases (chemistry), Phosphatidylinositol 3-Kinases (genetics), Phosphatidylinositol 3-Kinases (metabolism), Protein Conformation (MeSH), Protein Domains (MeSH), Recombinant Fusion Proteins (chemistry), Recombinant Fusion Proteins (genetics), Saccharomyces cerevisiae (chemistry), Saccharomyces cerevisiae (metabolism), Saccharomyces cerevisiae Proteins (chemistry), Saccharomyces cerevisiae Proteins (genetics), Saccharomyces cerevisiae Proteins (metabolism), Tacrolimus Binding Proteins (chemistry), Tacrolimus Binding Proteins (genetics), Tacrolimus Binding Proteins (metabolism).
- MESH :
- chemical , chemistry : Phosphatidylinositol 3-Kinases, Recombinant Fusion Proteins, Saccharomyces cerevisiae Proteins, Tacrolimus Binding Proteins.
- chemical , genetics : Phosphatidylinositol 3-Kinases, Recombinant Fusion Proteins, Saccharomyces cerevisiae Proteins, Tacrolimus Binding Proteins.
- chemical , metabolism : Liposomes, Phosphatidylinositol 3-Kinases, Saccharomyces cerevisiae Proteins, Tacrolimus Binding Proteins.
- chemistry : Saccharomyces cerevisiae.
- metabolism : Cell Membrane, Saccharomyces cerevisiae.
- Circular Dichroism, Humans, Micelles, Models, Molecular, Molecular Dynamics Simulation, Mutation, Nuclear Magnetic Resonance, Biomolecular, Protein Conformation, Protein Domains.
Abstract
Increased efforts have been undertaken to better understand the formation of signaling complexes at cellular membranes. Since the preparation of proteins containing a transmembrane domain or a prenylation motif is generally challenging an alternative membrane anchoring unit that is easy to attach, water-soluble and binds to different membrane mimetics would find broad application. The 33-residue long FATC domain of yeast TOR1 (y1fatc) fulfills these criteria and binds to neutral and negatively charged micelles, bicelles, and liposomes. As a case study, we fused it to the FKBP506-binding region of the protein FKBP38 (FKBP38-BD) and used 1 H-15 N NMR spectroscopy to characterize localization of the chimeric protein to micelles, bicelles, and liposomes. Based on these and published data for y1fatc, its use as a C-terminally attachable membrane anchor for other proteins is compatible with a wide range of buffer conditions (pH circa 6-8.5, NaCl 0 to >150 mM, presence of reducing agents, different salts such as MgCl2 and CaCl2 ). The high water-solubility of y1fatc enables its use for titration experiments against a membrane-localized interaction partner of the fused target protein. Results from studies with peptides corresponding to the C-terminal 17-11 residues of the 33-residue long domain by 1D 1 H NMR and CD spectroscopy indicate that they still can interact with membrane mimetics. Thus, they may be used as membrane anchors if the full y1fatc sequence is disturbing or if a chemically synthesized y1fatc peptide shall be attached by native chemical ligation, for example, unlabeled peptide to 15 N-labeled target protein for NMR studies.
DOI: 10.1002/pro.3321
PubMed: 29024217
PubMed Central: PMC5775168
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.</title>
<author><name sortKey="De Cicco, Maristella" sort="De Cicco, Maristella" uniqKey="De Cicco M" first="Maristella" last="De Cicco">Maristella De Cicco</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching</wicri:regionArea>
<wicri:noRegion>Garching</wicri:noRegion>
<orgName type="university">Université technique de Munich</orgName>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Milroy, Lech G" sort="Milroy, Lech G" uniqKey="Milroy L" first="Lech-G" last="Milroy">Lech-G Milroy</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biomedical Technology, Laboratory of Chemical Biology, Technische Universiteit Eindhoven, Eindhoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Biomedical Technology, Laboratory of Chemical Biology, Technische Universiteit Eindhoven, Eindhoven</wicri:regionArea>
<wicri:noRegion>Eindhoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dames, Sonja A" sort="Dames, Sonja A" uniqKey="Dames S" first="Sonja A" last="Dames">Sonja A. Dames</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching</wicri:regionArea>
<wicri:noRegion>Garching</wicri:noRegion>
<orgName type="university">Université technique de Munich</orgName>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg</wicri:regionArea>
<wicri:noRegion>Neuherberg</wicri:noRegion>
<wicri:noRegion>Neuherberg</wicri:noRegion>
<wicri:noRegion>Neuherberg</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29024217</idno>
<idno type="pmid">29024217</idno>
<idno type="doi">10.1002/pro.3321</idno>
<idno type="pmc">PMC5775168</idno>
<idno type="wicri:Area/Main/Corpus">000704</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000704</idno>
<idno type="wicri:Area/Main/Curation">000704</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000704</idno>
<idno type="wicri:Area/Main/Exploration">000704</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.</title>
<author><name sortKey="De Cicco, Maristella" sort="De Cicco, Maristella" uniqKey="De Cicco M" first="Maristella" last="De Cicco">Maristella De Cicco</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching</wicri:regionArea>
<wicri:noRegion>Garching</wicri:noRegion>
<orgName type="university">Université technique de Munich</orgName>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Milroy, Lech G" sort="Milroy, Lech G" uniqKey="Milroy L" first="Lech-G" last="Milroy">Lech-G Milroy</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biomedical Technology, Laboratory of Chemical Biology, Technische Universiteit Eindhoven, Eindhoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Biomedical Technology, Laboratory of Chemical Biology, Technische Universiteit Eindhoven, Eindhoven</wicri:regionArea>
<wicri:noRegion>Eindhoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dames, Sonja A" sort="Dames, Sonja A" uniqKey="Dames S" first="Sonja A" last="Dames">Sonja A. Dames</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching</wicri:regionArea>
<wicri:noRegion>Garching</wicri:noRegion>
<orgName type="university">Université technique de Munich</orgName>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg</wicri:regionArea>
<wicri:noRegion>Neuherberg</wicri:noRegion>
<wicri:noRegion>Neuherberg</wicri:noRegion>
<wicri:noRegion>Neuherberg</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Protein science : a publication of the Protein Society</title>
<idno type="eISSN">1469-896X</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cell Membrane (metabolism)</term>
<term>Circular Dichroism (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Liposomes (metabolism)</term>
<term>Micelles (MeSH)</term>
<term>Models, Molecular (MeSH)</term>
<term>Molecular Dynamics Simulation (MeSH)</term>
<term>Mutation (MeSH)</term>
<term>Nuclear Magnetic Resonance, Biomolecular (MeSH)</term>
<term>Phosphatidylinositol 3-Kinases (chemistry)</term>
<term>Phosphatidylinositol 3-Kinases (genetics)</term>
<term>Phosphatidylinositol 3-Kinases (metabolism)</term>
<term>Protein Conformation (MeSH)</term>
<term>Protein Domains (MeSH)</term>
<term>Recombinant Fusion Proteins (chemistry)</term>
<term>Recombinant Fusion Proteins (genetics)</term>
<term>Saccharomyces cerevisiae (chemistry)</term>
<term>Saccharomyces cerevisiae (metabolism)</term>
<term>Saccharomyces cerevisiae Proteins (chemistry)</term>
<term>Saccharomyces cerevisiae Proteins (genetics)</term>
<term>Saccharomyces cerevisiae Proteins (metabolism)</term>
<term>Tacrolimus Binding Proteins (chemistry)</term>
<term>Tacrolimus Binding Proteins (genetics)</term>
<term>Tacrolimus Binding Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Conformation des protéines (MeSH)</term>
<term>Dichroïsme circulaire (MeSH)</term>
<term>Domaines protéiques (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Liposomes (métabolisme)</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Micelles (MeSH)</term>
<term>Modèles moléculaires (MeSH)</term>
<term>Mutation (MeSH)</term>
<term>Phosphatidylinositol 3-kinases (composition chimique)</term>
<term>Phosphatidylinositol 3-kinases (génétique)</term>
<term>Phosphatidylinositol 3-kinases (métabolisme)</term>
<term>Protéines de Saccharomyces cerevisiae (composition chimique)</term>
<term>Protéines de Saccharomyces cerevisiae (génétique)</term>
<term>Protéines de Saccharomyces cerevisiae (métabolisme)</term>
<term>Protéines de fusion recombinantes (composition chimique)</term>
<term>Protéines de fusion recombinantes (génétique)</term>
<term>Protéines de liaison au tacrolimus (composition chimique)</term>
<term>Protéines de liaison au tacrolimus (génétique)</term>
<term>Protéines de liaison au tacrolimus (métabolisme)</term>
<term>Résonance magnétique nucléaire biomoléculaire (MeSH)</term>
<term>Saccharomyces cerevisiae (composition chimique)</term>
<term>Saccharomyces cerevisiae (métabolisme)</term>
<term>Simulation de dynamique moléculaire (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Phosphatidylinositol 3-Kinases</term>
<term>Recombinant Fusion Proteins</term>
<term>Saccharomyces cerevisiae Proteins</term>
<term>Tacrolimus Binding Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Phosphatidylinositol 3-Kinases</term>
<term>Recombinant Fusion Proteins</term>
<term>Saccharomyces cerevisiae Proteins</term>
<term>Tacrolimus Binding Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Liposomes</term>
<term>Phosphatidylinositol 3-Kinases</term>
<term>Saccharomyces cerevisiae Proteins</term>
<term>Tacrolimus Binding Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr"><term>Phosphatidylinositol 3-kinases</term>
<term>Protéines de Saccharomyces cerevisiae</term>
<term>Protéines de fusion recombinantes</term>
<term>Protéines de liaison au tacrolimus</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Phosphatidylinositol 3-kinases</term>
<term>Protéines de Saccharomyces cerevisiae</term>
<term>Protéines de fusion recombinantes</term>
<term>Protéines de liaison au tacrolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cell Membrane</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Liposomes</term>
<term>Membrane cellulaire</term>
<term>Phosphatidylinositol 3-kinases</term>
<term>Protéines de Saccharomyces cerevisiae</term>
<term>Protéines de liaison au tacrolimus</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Circular Dichroism</term>
<term>Humans</term>
<term>Micelles</term>
<term>Models, Molecular</term>
<term>Molecular Dynamics Simulation</term>
<term>Mutation</term>
<term>Nuclear Magnetic Resonance, Biomolecular</term>
<term>Protein Conformation</term>
<term>Protein Domains</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conformation des protéines</term>
<term>Dichroïsme circulaire</term>
<term>Domaines protéiques</term>
<term>Humains</term>
<term>Micelles</term>
<term>Modèles moléculaires</term>
<term>Mutation</term>
<term>Résonance magnétique nucléaire biomoléculaire</term>
<term>Simulation de dynamique moléculaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Increased efforts have been undertaken to better understand the formation of signaling complexes at cellular membranes. Since the preparation of proteins containing a transmembrane domain or a prenylation motif is generally challenging an alternative membrane anchoring unit that is easy to attach, water-soluble and binds to different membrane mimetics would find broad application. The 33-residue long FATC domain of yeast TOR1 (y1fatc) fulfills these criteria and binds to neutral and negatively charged micelles, bicelles, and liposomes. As a case study, we fused it to the FKBP506-binding region of the protein FKBP38 (FKBP38-BD) and used <sup>1</sup>
H-<sup>15</sup>
N NMR spectroscopy to characterize localization of the chimeric protein to micelles, bicelles, and liposomes. Based on these and published data for y1fatc, its use as a C-terminally attachable membrane anchor for other proteins is compatible with a wide range of buffer conditions (pH circa 6-8.5, NaCl 0 to >150 mM, presence of reducing agents, different salts such as MgCl<sub>2</sub>
and CaCl<sub>2</sub>
). The high water-solubility of y1fatc enables its use for titration experiments against a membrane-localized interaction partner of the fused target protein. Results from studies with peptides corresponding to the C-terminal 17-11 residues of the 33-residue long domain by 1D <sup>1</sup>
H NMR and CD spectroscopy indicate that they still can interact with membrane mimetics. Thus, they may be used as membrane anchors if the full y1fatc sequence is disturbing or if a chemically synthesized y1fatc peptide shall be attached by native chemical ligation, for example, unlabeled peptide to <sup>15</sup>
N-labeled target protein for NMR studies.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29024217</PMID>
<DateCompleted><Year>2019</Year>
<Month>01</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>02</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-896X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>2</Issue>
<PubDate><Year>2018</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Protein science : a publication of the Protein Society</Title>
<ISOAbbreviation>Protein Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.</ArticleTitle>
<Pagination><MedlinePgn>546-560</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.3321</ELocationID>
<Abstract><AbstractText>Increased efforts have been undertaken to better understand the formation of signaling complexes at cellular membranes. Since the preparation of proteins containing a transmembrane domain or a prenylation motif is generally challenging an alternative membrane anchoring unit that is easy to attach, water-soluble and binds to different membrane mimetics would find broad application. The 33-residue long FATC domain of yeast TOR1 (y1fatc) fulfills these criteria and binds to neutral and negatively charged micelles, bicelles, and liposomes. As a case study, we fused it to the FKBP506-binding region of the protein FKBP38 (FKBP38-BD) and used <sup>1</sup>
H-<sup>15</sup>
N NMR spectroscopy to characterize localization of the chimeric protein to micelles, bicelles, and liposomes. Based on these and published data for y1fatc, its use as a C-terminally attachable membrane anchor for other proteins is compatible with a wide range of buffer conditions (pH circa 6-8.5, NaCl 0 to >150 mM, presence of reducing agents, different salts such as MgCl<sub>2</sub>
and CaCl<sub>2</sub>
). The high water-solubility of y1fatc enables its use for titration experiments against a membrane-localized interaction partner of the fused target protein. Results from studies with peptides corresponding to the C-terminal 17-11 residues of the 33-residue long domain by 1D <sup>1</sup>
H NMR and CD spectroscopy indicate that they still can interact with membrane mimetics. Thus, they may be used as membrane anchors if the full y1fatc sequence is disturbing or if a chemically synthesized y1fatc peptide shall be attached by native chemical ligation, for example, unlabeled peptide to <sup>15</sup>
N-labeled target protein for NMR studies.</AbstractText>
<CopyrightInformation>© 2017 The Protein Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Cicco</LastName>
<ForeName>Maristella</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Milroy</LastName>
<ForeName>Lech-G</ForeName>
<Initials>LG</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Technology, Laboratory of Chemical Biology, Technische Universiteit Eindhoven, Eindhoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dames</LastName>
<ForeName>Sonja A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo><Affiliation>Department of Chemistry, Technische Universität München, Biomolecular NMR Spectroscopy, Garching, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Protein Sci</MedlineTA>
<NlmUniqueID>9211750</NlmUniqueID>
<ISSNLinking>0961-8368</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C471205">FKBP8 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008823">Micelles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.1.137</RegistryNumber>
<NameOfSubstance UI="C083324">TOR1 protein, S cerevisiae</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 5.2.1.-</RegistryNumber>
<NameOfSubstance UI="D022021">Tacrolimus Binding Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008823" MajorTopicYN="N">Micelles</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D029701" MajorTopicYN="N">Saccharomyces cerevisiae Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D022021" MajorTopicYN="N">Tacrolimus Binding Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">NMR spectroscopy</Keyword>
<Keyword MajorTopicYN="Y">membrane mimetic</Keyword>
<Keyword MajorTopicYN="Y">protein membrane anchoring</Keyword>
<Keyword MajorTopicYN="Y">protein-lipid interactions</Keyword>
<Keyword MajorTopicYN="Y">protein-membrane interactions</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>10</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>10</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>10</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>1</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>10</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29024217</ArticleId>
<ArticleId IdType="doi">10.1002/pro.3321</ArticleId>
<ArticleId IdType="pmc">PMC5775168</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Sci STKE. 2003 Mar 11;2003(173):pe10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12631689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1996 Feb 13;35(6):1803-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8639661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2010 Mar 5;285(10):7766-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20042596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2004;278:313-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15318002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biomol NMR. 1995 Nov;6(3):277-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8520220</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1995 Oct 6;270(5233):50-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7569949</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Phys Chem B. 2014 Feb 13;118(6):1481-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24451004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aging (Albany NY). 2009 Apr 20;1(4):357-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20157523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obes Rev. 2012 Dec;13 Suppl 2:58-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23107260</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 2;279(1):772-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14578359</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Phys Chem B. 2014 May 8;118(18):4817-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24725177</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biochem. 2008 Jan;307(1-2):249-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17874175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2006 Feb 21;45(7):2339-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16475823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 1997 Dec 29;241(3):704-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9434772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2000 Sep 12;39(36):11024-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10998239</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chembiochem. 2010 Nov 2;11(16):2251-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20922740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2011 Mar 4;144(5):757-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21376236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosignals. 2008;16(4):318-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18635947</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Chem Biol. 2015 Feb 20;10(2):475-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25386784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Sci. 2007 Oct;16(10):2153-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17893361</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2010 Apr 16;141(2):290-303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20381137</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2005 May 27;280(21):20558-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15772072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 2014 May 2;588(9):1755-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24704685</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Sep;1791(9):949-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19264150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2009;498:265-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18988031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18216768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Sci. 2012 Oct;21(10):1566-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22825779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Protoc Protein Sci. 2001 May;Chapter 15:Unit15.1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18429125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2012 Jun 19;51(24):4909-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22620485</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2007 Nov 9;318(5852):977-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17991864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2001 Nov 30;294(5548):1942-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11729323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Membranes (Basel). 2015 Sep 29;5(4):553-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26426064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2013 Feb 6;135(5):1919-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23294159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Sci. 2011 Oct 15;124(Pt 20):3381-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22010196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 2000 May;25(5):225-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10782091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5927-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23530194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Cell Biol. 2011 Dec;23(6):744-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21963299</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2012 Apr 13;149(2):274-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22500797</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2008 Sep 19;283(38):25963-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18658153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1989 Jun 13;28(12):5113-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2669968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2000 Nov 24;275(47):37011-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10973982</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2011 Oct 21;286(42):36907-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21846933</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Phys Chem B. 2005 Aug 11;109(31):15098-106</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16852911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Lipid Res. 2010 Aug;51(8):2454-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20348589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2006 Oct 3;45(39):11713-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17002272</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Mol Cell Biol. 2001 Jul;2(7):504-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11433364</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2011 Aug;1808(8):1957-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21477581</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Cell Biol. 2003 Jan;5(1):28-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12510191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Sci. 2015 Mar 15;128(6):1065-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25774051</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 2005 Jul 20;24(14):2688-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15990872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Cell. 2003 May;14(5):1882-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12802062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2008 Oct 10;32(1):140-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18851840</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Cell. 2003 Mar;14(3):1204-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12631735</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2013 Mar 6;135(9):3367-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23409921</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2013 Jul 5;288(27):20046-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23671275</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2002 Aug 2;277(31):28127-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12000755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Cell. 2009 Mar;20(5):1565-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19144819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2010 Mar 19;285(12):8621-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20048149</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
<li>Pays-Bas</li>
</country>
<region><li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement><li>Munich</li>
</settlement>
<orgName><li>Université technique de Munich</li>
</orgName>
</list>
<tree><country name="Allemagne"><region name="Bavière"><name sortKey="De Cicco, Maristella" sort="De Cicco, Maristella" uniqKey="De Cicco M" first="Maristella" last="De Cicco">Maristella De Cicco</name>
</region>
<name sortKey="Dames, Sonja A" sort="Dames, Sonja A" uniqKey="Dames S" first="Sonja A" last="Dames">Sonja A. Dames</name>
<name sortKey="Dames, Sonja A" sort="Dames, Sonja A" uniqKey="Dames S" first="Sonja A" last="Dames">Sonja A. Dames</name>
</country>
<country name="Pays-Bas"><noRegion><name sortKey="Milroy, Lech G" sort="Milroy, Lech G" uniqKey="Milroy L" first="Lech-G" last="Milroy">Lech-G Milroy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000469 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000469 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= RapamycinFungusV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:29024217 |texte= Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29024217" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a RapamycinFungusV1
This area was generated with Dilib version V0.6.38. |